CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers-Reference-Cited by-同舟云学术

CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers

Published:2011-12-27 Issue:3 Volume:11 Page:670-679
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Cheng Mangeng,Quail Matthew R.,Gingrich Diane E.,Ott Gregory R.,Lu Lihui,Wan Weihua,Albom Mark S.,Angeles Thelma S.,Aimone Lisa D.,Cristofani Flavio,Machiorlatti Rodolfo,Abele Cristina,Ator Mark A.,Dorsey Bruce D.,Inghirami Giorgio,Ruggeri Bruce A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rhodium‐Catalyzed Asymmetric Hydrogenation of Tetrasubstituted α,β‐Unsaturated Amides: Efficient Access to Chiral β‐Amino Amides^†;Chinese Journal of Chemistry;2024-07-04

2. The crystal structure of 5′-(furan-2-yl)-3′-((4-methylphenyl)sulfonamido)-3′,4′,5′,6′-tetrahydro-[1,1′:3′,1″-terphenyl]-4′-carboxylic acid, C₃₀H₂₇NO₅S;Zeitschrift für Kristallographie - New Crystal Structures;2023-12-08

3. Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability;Blood Advances;2023-07-28

4. New perspectives for targeting therapy in ALK-positive human cancers;Oncogene;2023-05-06

5. Enzymatic Strategies for the Preparation of Pharmaceutically Important Amino Acids through Hydrolysis of Amino Carboxylic Esters and Lactams;Current Medicinal Chemistry;2022-12